89937-52-0

Usage

InChI:InChI=1/C6H14N2O2S/c7-1-2-8-3-5-11(9,10)6-4-8/h1-7H2

Upstream product

• 79207-43-5 4-Cyanomethyl-thiomorpholin-S-dioxid 

Downstream Products

• 173337-84-3 5(S)-tert-butoxycarbonylamino-4(S)-hydroxy-7(S)-isopropyl-2(R)-methyl-8-[4-methoxy-3-(3-methoxypropyloxy)-phenyl]-octanoic acid N-[2-(1,1-dioxothiomorpholino)ethyl] amide 
• 1021869-47-5 C₂₃H₃₂N₄O₆S₂ 
• 1117686-28-8 4-{[4-(2,6-dimethylpyridin-3-yl)oxypyridin-2-yl]amino}-N-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethyl]benzamide 
• 1300746-38-6 2-[(4S)-6-(4-chlorophenyl)-1-methyl-8-(methyloxy)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-[2-(1,1-dioxido-4-thiomorpholinyl)ethyl]acetamide 
• 1256969-01-3 C₁₉H₂₂N₄O₃S 
• 1392310-92-7 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-(((2-(1,1-dioxido-4-thiomorpholinyl)ethyl)carbamoyl)amino)-1-isopropenyl-5a,5b,8,8,11a-pentamethyl-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoic acid 
• 1392314-22-5 N-(2-(1,1-dioxido-4-thiomorpholinyl)ethyl)-2-nitrobenzenesulfonamide 
• 1392314-28-1 N,N-bis(2-(1,1-dioxido-4-thiomorpholinyl)ethyl)-2-nitrobenzenesulfonamide 
• 1392314-27-0 N-(2-(1,1-dioxido-4-thiomorpholinyl)ethyl)-N-(3-methoxypropyl)-2-nitrobenzenesulfonamide 
• 1392314-26-9 N-(2-(1,1-dioxido-4-thiomorpholinyl)ethyl)-N-(2-methoxyethyl)-2-nitrobenzenesulfonamide 

Relevant academic research and scientific papers

Aryl compounds with aminoalkyl substituents and their use

The present application relates to novel aryl compounds with aminoalkyl substituents, to processes for their preparation, to their use for treatment and/or prevention of diseases and to their use for the preparation of medicaments for treatment and/or prevention of diseases, in particular for treatment and/or prevention of hyperproliferative and angiogenic diseases and those diseases which arise from metabolic adaptation to hypoxic states. Such treatments can be carried out as monotherapy or also in combination with other medicaments or further therapeutic measures.